Progression Clinical Trials

33 clinical trials for Progression across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China — RECRUITING
• Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma — RECRUITING · PHASE2
• Liver Disease and Other Systemic Diseases — RECRUITING
• Omitting CTV for Primary Tumor in LS-SCLC — RECRUITING · PHASE3
• The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) — RECRUITING · NA
• Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors — RECRUITING · PHASE2
• A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules — RECRUITING · PHASE2
• A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components — RECRUITING · NA
• Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III — COMPLETED · PHASE3
• Effects of Progressive Relaxation Exercises — COMPLETED · NA
• Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data — COMPLETED
• The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination — ACTIVE_NOT_RECRUITING
• Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL — TERMINATED · PHASE1
• Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer — OTHER
• Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age. — COMPLETED
• Soluble B7-H3 as a Biomarker for Osteosarcoma — OTHER
• Laser Ablation After Stereotactic Radiosurgery — COMPLETED
• Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer — COMPLETED
• Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation — OTHER
• Early Neurological Deterioration in Recent Small Subcortical Infarction — OTHER
• Intrapartum Translabial Ultrasonography Reliability — OTHER
• Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial — OTHER · NA
• A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1 — NOT_YET_RECRUITING · NA
• Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression — COMPLETED · PHASE3
• Prospective Cohort Study of Disease and Outcomes in Cirrhosis — OTHER
• Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma — WITHDRAWN · PHASE1
• Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer — COMPLETED
• Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. — OTHER
• Pronostic and Predictive Value of EMT in Localized Lung Cancer — OTHER
• PD-L1 Expression in Advanced Osteosarcoma — OTHER
• Kidney Function and Cardiovascular Events: Cohort Study in General Population — OTHER
• A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) — OTHER
• Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy — COMPLETED · NA

Refine this search